At Atomic AI, we build artificial intelligence to pioneer new frontiers in drug discovery. Our unique R&D platform, an early version of which was featured on the cover of Science, enables the design of novel, RNA‑centric medicines for areas of high unmet need. We continue to advance this platform by developing new machine learning methods and unique foundation models fueled by our large-scale, in-house experimental data collection. We are an interdisciplinary team of scientists and engineers and believe our people are our greatest strength and the key to our success.
| Website | https://atomic.ai |
| Employees | 26 (14 on RocketReach) |
| Address | 610 22nd St, San Francisco, California 94107, US |
| Industry | Biotechnology Research |
| Keywords | Artificial Intelligence, Drug Discovery, Biotechnology, Machine Learning, Molecular Design, Pharmaceutical, Ai In Medicine, Precision Medicine, Computational Biology, Structural Biology, Therapeutics, Bioinformatics, Deep Learning, Genomics, Drug Development, Protein Engineering, Medicinal Chemistry, Molecular Modeling, Bioscience |
| Competitors | Amazon, Microsoft, IBM, Google, Salesforce, NVIDIA, OpenAI, DataRobot, C3 AI, H2O.ai +38 more (view full list) |
Looking for a particular Atomic AI employee's phone or email?
Raphael Townshend is the Founder and CEO of Atomic AI.
14 people are employed at Atomic AI.
Atomic AI is based in San Francisco, California.